| 000 | 01705 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515150935.0 | ||
| 264 | 0 | _c20090526 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a1532-1983 | ||
| 024 | 7 |
_a10.1016/j.clnu.2008.09.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Chun-Che | |
| 245 | 0 | 0 |
_aVitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin. _h[electronic resource] |
| 260 |
_bClinical nutrition (Edinburgh, Scotland) _cFeb 2009 |
||
| 300 |
_a34-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntioxidants _xmetabolism |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFolic Acid Deficiency _xblood |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 |
_aIron _xblood |
| 650 | 0 | 4 | _aIron Deficiencies |
| 650 | 0 | 4 | _aLipid Peroxidation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNutritional Status |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 | _aOxidative Stress |
| 650 | 0 | 4 |
_aRibavirin _xadverse effects |
| 650 | 0 | 4 |
_aVitamin B 6 Deficiency _xblood |
| 650 | 0 | 4 |
_aVitamin B Complex _xblood |
| 650 | 0 | 4 |
_aVitamin B Deficiency _xblood |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aYin, Mei-Chin | |
| 773 | 0 |
_tClinical nutrition (Edinburgh, Scotland) _gvol. 28 _gno. 1 _gp. 34-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clnu.2008.09.003 _zAvailable from publisher's website |
| 999 |
_c18497415 _d18497415 |
||